AN \u3ci\u3eIN VITRO\u3c/i\u3e MICRO-VOLUME PROCEDURE FOR RAPID
MEASUREMENT OF ERYTHROCYTIC HEXOSE
MONOPHOSPHATE SHUNT ACTIVITY by Baird, J. Kevin et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Public Health Resources Public Health Resources
1984
AN IN VITRO MICRO-VOLUME
PROCEDURE FOR RAPID MEASUREMENT
OF ERYTHROCYTIC HEXOSE
MONOPHOSPHATE SHUNT ACTIVITY
J. Kevin Baird
ALERTAsia Foundation, jkevinbaird@yahoo.com
Joan E. Decker-Jackson
Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington,
DC
David E. Davidson Jr.
Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington,
DC
Follow this and additional works at: http://digitalcommons.unl.edu/publichealthresources
This Article is brought to you for free and open access by the Public Health Resources at DigitalCommons@University of Nebraska - Lincoln. It has
been accepted for inclusion in Public Health Resources by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.
Baird, J. Kevin; Decker-Jackson, Joan E.; and Davidson, David E. Jr., "AN IN VITRO MICRO-VOLUME PROCEDURE FOR RAPID
MEASUREMENT OF ERYTHROCYTIC HEXOSE MONOPHOSPHATE SHUNT ACTIVITY" (1984). Public Health Resources.
410.
http://digitalcommons.unl.edu/publichealthresources/410
Inl. J. Biochem, Vol. 16, No. 10, pp. 1049-1052, 1984
Printed in Great Britain
0020-711 Xj84 53.00 + 0.00
Pergamon Press Ltd
AN IN VITRO MICRO-VOLUME PROCEDURE FOR RAPID
MEASUREMENT OF ERYTHROCYTIC HEXOSE
MONOPHOSPHATE SHUNT ACTIVITY
J. KEVIN BAIRD*, JOAN E. DECKER-JACKSON and DAVID E. DAVIDSON JR
Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Walter Reed Army
Medical Center, Washington, DC 20307, U.S.A. [Tel. 301-427-5122]
(Received 13 January 1984)
Abstract-v-I. A radiometric micro-volume procedure for measurement of erythrocytic hexose mono-
phosphate shunt (HMS) activity in intact cells in vitro is described.
2. The procedure is rapid, allowing 200 individual HMS determinations in a single experiment of 5 hr
duration.
3. The procedure is reproducible, yielding HMS activity means insignificantly different (P > 0.05)
between replicate experiments.
4. A profile of sodium nitrite-induced HMS stimulation is reported: HMS was elevated 2-fold
(P < 0.001) between zero and 2.5mM NaN02; HMS elevation was more distinct (7-fold) between 2.5 and
5.0 mM NaNOz; maximum activity (22-fold) was observed between 10 and 20 mM NaN02;
> 20 mM NaNOz caused significant (P < 0.001) diminution of HMS; glucose carbon recycling through
the HMS occurred only with > 2.5 mM NaNO z where this process contributed :::; 16% to total HMS
activity.
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INTRODUCTION
In persons genetically deficient in erythrocytic
~lucose-6-phosphate dehydrogenase (G6PD), a he-
molytic anemia is generally believed to result from
.the inability of the deficient erythrocyte to generate
reduction potential in response to oxidative chal-
nge presented by certain drugs (Carson and
rischer, 1966; Beutler, 1978; Gordon-Smith, 1980);
()wever, the mechanism by which oxidation may be
ated to hemolysis is unknown (Keller, 1971; Car-
net al., 1981). In this regard, the HMS is a likely
bject of investigation because HMS-generated
DPH is required for reduction of glutathione, and
uced glutathione affords the primary protection
ainst oxidative challenge in the erythrocyte (Keller,
;71; Srivastava et aI., 1980). The determination of
f\,1S activity levels has recently been used by Kirk-
n et al. (1980) for the investigation of possible
des of metabolic regulation operating on the
nt, and by Carson et al. (1981) to differentiate at
t two mechanisms through which HMS stimu-
n is achieved.
he methods used in these and similar in-
igations (Rose and O'Connell, 1963; Welt et al.,
; Gaetani et al., 1974; Harvey and Kaneko, 1977)
odified versions of the procedure described by
and Yonemoto (1958). In these procedures,
I of drug-erythrocyte-glucose isotope mixture
ubated in a sealed vessel containing a hydroxide
from which HMS-liberated 14COZ is quantitated.
procedure we have developed also uses re-
al of HMS-generated 14COZ but has been de-
to whom inquiries and reprint requests should be
ressed.
ews of the authors do not reflect the opinions of the
artment of the Army or the Department of Defense.
signed to allow simultaneous measurement of several
treatment groups with a high number of replicates.
This design is illustrated in Fig. I. The final incu-
bation volume is 50 pi and the 14COZ trap seals the
microtiter well which serves as the incubation vessel.
This report presents the results obtained using the
micro-volume technique. The procedure appears to
be somewhat inefficient in recovery of HMS-liberated
14COZ, but it offers replicable, quantitative data which
may be statistically analyzed with a high degree of
confidence.
MATERIALS AND METHODS
Buffers
A physiological balanced salts solution (PBSS) buffer was
prepared by addition of the following chemicals (Sigma
Fig. I. Schematic representation of hexose monophosphate
shunt (HMS) activity measurement by the micro-volume
procedure. The incubation mixture is 50 III and the Ba(OH)2
soaked CO2 trap is 20mrrr', The Ba14COJ product precip-
itates in the filter pad and its emission is quantitated by gas
flow spectrometry.
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Chemical Co., St Louis, Missouri, U.S.A.) to sterile distilled
and deionized water (Travenol Laboratories, Deerfield,
Illinois, U.S.A.) to the indicated final concentrations: NaCI,
112mM; KCI, 5.4 mM; CaCI, 1.26mM; KH 2P04,0.44 mM;
MgS04, 0.42 mM; Na 2HP04, 10.0 mM. The pH of this
solution was adjusted to 7.4 with another solution prepared
as above except that Na 2HP04 was substituted with
10.0mM NaH 2P04. The PBSS solution (500 ml) was ster-
ilized by filtration through a Nalgene type LS sterilization
filter unit (Sybron Corp., Rochester, New York, U.S.A.)
and stored at 4°C.
A phosphate buffered salts (PBS) buffer (pH 7.4) was
prepared as described above except for deletion of CaCI"
KCI and MgS04. -
Isotopes
D[I-14C]glucose and D[2- 14C]glucose were obtained at
50 /lCi/250 /ll 2% ethanol in water (Amersham Corp., Ar-
lington Heights, Illinois, U.S.A.). D[l-14C]glucose and
D[2-14C]glucose had specific activities of 59.8 and
55 /lCi//lmol, respectively. Isotope solutions were prepared
in PBSS to yield 100,000dpm per 25 pI and a final glucose
concentration of 3.0 mM by addition of reagent grade
D-glucose (Sigma Chemical Co., St Louis, Missouri,
U.S.A.). Final specific activities were 0.60 and
0.55 PCi/{lmol for D[I-14C]glucose and D[2- 14C]glucose, re-
spectively. Solutions were sterilized by membrane filtration
(Gelman Acrodisc, disposable filter unit, 0.2 /lm pore size,
Gelman Sciences Inc., Ann Arbor, Michigan, U.S.A.),
dispensed into sterile screw cap vials and stored at - 25°C.
Reagents
Reagent grade sodium nitrite (Aldrich Chemical Co., Inc.,
Milwaukee, Wisconsin, U.S.A.) stock solution (250 mM)
was prepared in PBSS. Solutions for tests were prepared by
dilution of the stock in PBSS. Nitrite solutions older than
I hr were not used.
Saturated barium hydroxide was prepared by addition of
250 g reagent grade anhydrous barium hydroxide (Fisher
Scientific Co., Fair Lawn, New Jersey, U.S.A.) to approx.
300 ml autoclaved distilled and deionized water, cooled
under vacuum. This mixture was gently shaken under
vacuum for 10min and then held under vacuum overnight
before use. The saturated stock Ba(OHh solution was
maintained under vacuum to minimize exposure to atmo-
spheric CO2,
Erythrocytes
Ten ml whole blood were withdrawn by venipuncture
from a 24-year-old Caucasian male (with no family history
of hemolytic sensitivity), added to 40 ml PBS (25°C) and
centrifuged immediately at 4°C, 500g for 10 min. The buffy
coat was removed by aspiration prior to decanting the
supernatant. The red cell pellet was resuspended in 40 ml
PBSS (4°C) and again centrifuged as before. This centrifugal
wash was repeated once more and the pellet plus PBSS was
adjusted to a total volume of 10m!. Without disturbing the
red cell pellet, 500 mg human serum albumin (essentially
globulin free, Fraction V, Sigma Chemical Co.) was allowed
to dissolve into the supernatant. The preparation was mixed
gently and kept at O°C until used. Red cell preparations
older than two hours were not used. Albumin was added to
the incubation mixture as a component to aid in solu-
bilization of hydrophobic HMS-stimulating agents used in
related experiments.
Incubation
Twenty-five /ll of 14C-glucose solution were added to each
well of a microtiter tray (Unipec Inc., Rockville, Maryland,
U.S.A.). Sodium nitrite solution (12.5 /ll) was added to these
wells immediately before addition of red blood cells. For
measurement of nonstimulated HMS activity, PBSS was
substituted for the nitrite solution. A dropper bottle of
saturated Ba(OH)2 solution and filter pads (circular
20 mnr', Scheicher and Schull Inc., Keene, New Hampshire'
U.S.A.) were prepared prior to addition of erythrocytes, to
ensure rapid sealing of microtiter wells and to minimize
air-exposure of the stock bottle of hydroxide reagent.
Red cell suspension (12.5 (d, O°C) was added to each well
of a replicate set of ten wells. One drop of Ba(OH)2 was
quickly added to each filter pad for the set and the soaked
pads were immediately placed over the wells. Trays were
sealed with friction-fit lids, shaken gently for about 10sec
and placed at 37°C under ambient atmosphere for 30 min.
HMS activity measure
Following incubation, filter pads were placed on alumi-
num planchettes (20 mm") held in plastic sample storage
trays and rapidly dried under infrared light. The emission
rate from Ba14CO) on each pad was determined using an
argon-methane (9: I) gas flow, «, {3 proportional spec-
trometer (LB 5110, Tennelec Inc., Oak Ridge, Tennessee,
U.S.A.). The following equation was used for HMS activity
calculation:
1.0/lCi 1.0/lmol glucose
dpm x x ------,-_i__
2.22 X 106 dpm n {I Ci
1000nmol CO2 1x x x--
pmol glucose 0.0125 ml RBC 0.5 hr
= nmol CO2 trapped' ml RBC- 1.hr- 1
Because 1mol 14C02 is released per mol 14C-glucose ox-
idized, it is valid to express HMS activity in terms of glucose
oxidized on the basis of recovered 14C02 quantitation, but
only if close to 100% recovery of 14C02 has been demon-
strated. As described herein, the micro-volume procedure
does not permit complete recovery of 14C02; incubation was
not terminated by addition of acid which would drive CO2
from solution. It was found that the micro-volume pro-
cedure was 32% efficient in recovery of 14C02 when acid
treatment was omitted. While it is possible to include acid
treatment in this procedure, doing so was found to decrease
the rapidity of the procedure. We elected to omit acid
treatment and to express HMS activity in terms of 14COZ
trapped rather than glucose oxidized.
The n /l Ci term in the equation depends on the specific
activity of the isotope and its treatment with non-labeled
substrate. In the experiments reported, n = 0.60
(D[1-14C]glucose) or 0.55 (D[2-14C]glucose).
Statistical analysis
Tests of significance of differences between two means
were conducted using the analysis of variance (ANOVA)
F-test as described by Sokal and Rohlf (1981). Tests of
significance of differences among more than two means were
conducted using the Student-Newman-Keuls (SNK) test.
All ANOV A tests were carried out using a 95% degree of
certainty and the statistical tables employed were those
compiled by Rohlf and Sokal (1981).
RESULTS
Stimulation of HMS activity from 0 to 80 mM
NaNG2 is shown in Fig. 2 where two activities are
plotted. These plots represent activity measured from
(I) D[I-14C]glucose incubation, and (2)
D[2-14C]glucose incubation. Activity measurement us-
ing the 1_14C glucose isotope accounts for glucose
molecules having made a single pass through the
HMS and the 2_14C glucose isotope provides a mea-
sure of glucose carbon recycling through the HMS
(Brin and Yonemoto, 1958). The sum of the two
activity means was considered to represent total
HMS activity.
Red cell HMS measurement
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Fig. 2. Activation of red cell hexose monophosphate shunt by increasing concentrations of sodium nitrite.
The two plots are those obtained from D[I-'4C]glucose incubation (e) or D[2-'4C]glucose incubation (0).
Each data point is the mean often simultaneously obtained measurements which are bracketed with limits
of the 95% confidence interval.
Total HMS acttvity was significantly greater
(P < 0.001) than activity measured from 1_ ' 4C glu-
cose incubation alone at sodium nitrite concen-
trations greater than 5.0 mM. Below this concen-
tration the two activities were insignificantly
(P > 0.05) different. At maximum HMS activity
(20mM NaNOz), glucose recycling accounted for
16% of total HMS activity.
Saturation of activity was observed between 10 and
20mM NaNOz, as evidenced by an insignificant
(P > 0.10) difference between the means. The 37%
decrease in HMS activity between 20 and 80 mM
NaN02 was significant (P < 0.001).
At the lowest nitrite concentration (0.625 mM),
HMS activity was significantly greater (P < 0.001)
than control activity. Each activity increase between
0, 0.625, and 2.5mM NaN02 was significant
(P < 0.001).
This experiment was repeated on a separate occa-
sion and HMS activities at several nitrite concen-
trations were compared by SNK and found to be
uniformly similar (P > 0.05). In both experiments
mean coefficients of variation were calculated for
each treatment group and found to range between 2
and 8%.
Statistical analysis of the means used to construct
the HMS stimulation plot illustrated in Fig. 2 has
provided a profile of red cell response to sodium
nitrite-induced oxidative challenge. The following
conclusions were drawn from these measurements:
(I) HMS activation induced by nitrite was sigmoid,
i.e. acceleration of HMS activity was bimodal; be-
tween 0 and 2.5 mM NaN02 the increase was linear
at a rate of 4.2 x 10-3 mol COz' mol NaN02-I .111.-
1.
Between 2.5 and 5.0 mM NaN02 the increase was
linear at a rate of 11.7 x 10- 3 mol CO2'mole
NaN0
2
-I. hr-'.
(2) Nitrite treatment saturated HMS activity be-
tween 10 and 20 mM NaNOz with an activity max-
imum of 57 units (nmol COz trapped' ml
RBC- I . hr- '). HMS activities at 10 and 20 mM
NaN02 were not significantly different.
(3) HMS activity means at concentrations greater
than 20 mM NaN02 were significantly diminished by
as much as 37%.
(4) Nitrite-induced glucose carbon recycling
through the HMS made a significant contribution to
total HMS activity at nitrite concentrations greater
than 2.5 mM NaNOz. Below 5.0 mM NaN02
recycling activity was not detectable.
Nitrite-induced glucose carbon recycling ac-
counted for ~ 16% of total HMS activity. Though
this contribution was significant (P < 0.001), it did
not alter the shape of the HMS response curve.
Activation was sigmoidal, saturated between 10 and
20 mM NaNOz, and was diminished between 20 and
80 mM NaN02 whether or not correction for
recycling was made.
DISCUSSION
The micro-volume procedure is a method in which
a reproducible, highly resolved profile of oxidant-
induced elevation of HMS activity can be obtained.
The method also offers the advantages of requiring
relatively minute quantities of blood and HMS stim-
ulant samples.
The units of HMS activity employed herein are
not directly comparable with unit values
reported elsewhere (usually as Ilmol glucose
oxidizedrnl RBC- " hr :"). However, comparison of
relative HMS activities reveals published values in
good agreement with those obtained using the micro-
volume procedure. For example, Methylene Blue-
induced elevation of HMS activity has been reported
as 51-fold (Gaetani et aI., 1974), 48-fold (Metz et al.,
1977), and 52-fold (Kirkman et al., 1980), whereas
the micro-volume procedure measured a 45-fold
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elevation of HMS above baseline activity (Baird,
1984). Further agreement is evident among estimates
of the Methylene Blue-induced glucose carbon recy-
cling contribution to total HMS activity; 34% (Brin
and Yonemoto, 1958), 27% (Harvey and Kaneko,
1977), 39% (Kirkman et al., 1980), and 28% using the
micro-volume procedure (data not given). These
comparisons indicate that the indirect measure of
HMS activity provided by this procedure is reliable.
The micro-volume procedure provides re-
producible estimates of HMS activity with rapidity,
allowing simultaneous measurement of a large num-
ber of experimental treatments with replication
sufficient for statistical analysis of the data with a
high degree of confidence. In this laboratory the
micro-volume procedure has been employed to exam-
ine the relationship between HMS activation and the
recently described proteolytic system in erythrocytes
which is activated by oxidative stress (Goldberg and
Boches, 1982). It has been found that sodium nitrite-
induced proteolysis is sensitive to the level of HMS
activity, whereas Methylene Blue may stimulate the
HMS independently of proteolytic activity (Baird,
1984). These observations may be related to the fact
that nitrite-induced activation of the HMS was dis-
tinctly sigmoidal (Fig. 2) and that induced by Meth-
ylene Blue was strongly hyperbolic (Kirkman et al.,
1980; Baird, 1984). The micro-volume procedure is
well-suited to detecting such differences in HMS
response.
This procedure also offers the advantage of re-
quiring relatively minute quantities of blood and test
oxidant. We have studied the oxidative activity of
various putative primaquine metabolites in human
erythrocytes in vitro (Baird et al., 1983). These com-
pounds are very limited in supply; reproducible esti-
mates of their effects on the HMS were obtained at
several concentrations with an expenditure of < 5 mg
per compound.
SUMMARY
A procedure which permits simultaneous mea-
surement of HMS activity in intact erythrocytes in
vitro from 200 individual incubation mixtures in a
single experiment is described. The incubation mix-
ture (washed RBC, oxidant, 14C-glucose; I: I :2) is
50 pI contained in a micro titer well sealed with a
Ba(OHksoaked paper filter pad which traps evolved
14C02 with 32% efficiency. The emission rate from
Ba l4C03 precipitate is measured directly from the
filter pad by a gas flow, a, fJ detector. The procedure
has been used to define a highly resolved, re-
producible profile of elevation of HMS activity with
increasing NaN02 concentration. The data given
illustrate the information-gathering potential this
method offers. The large number of replicates
possible allow one to detect relatively small de-
partures from normal HMS activity; e.g. elevation of
erythrocytic HMS activity in vivo by the hemolytic
antimalarial, primaquine, has been estimated to be
::s;0.20-fold above baseline (Welt et al., 1971). The
procedure may also be particularly useful when one
is experimentally limited by the amounts of blood
and/or test compound available.
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